Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study.
- DOI
- 10.1136/ard-2024-226129
- Published
- 2024 Nov 8
- Container
- Annals of the rheumatic diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/ard-2024-226129,
title = {Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study.},
author = {Berg JI and Nielsen SM and Malm E and Ioannidis JPA and Furst DE and Smolen JS and Taylor PC and Kristensen LE and Tarp S and Ellingsen T and Christensen R},
year = {2024},
journal = {Annals of the rheumatic diseases},
doi = {10.1136/ard-2024-226129},
url = {https://doi.org/10.1136/ard-2024-226129}
}RIS
TY - JOUR TI - Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study. AU - Berg JI AU - Nielsen SM AU - Malm E AU - Ioannidis JPA AU - Furst DE AU - Smolen JS AU - Taylor PC AU - Kristensen LE AU - Tarp S AU - Ellingsen T AU - Christensen R PY - 2024 JO - Annals of the rheumatic diseases DO - 10.1136/ard-2024-226129 UR - https://doi.org/10.1136/ard-2024-226129 ER -
APA
JI, B., SM, N., E, M., JPA, I., DE, F., JS, S., PC, T., LE, K., S, T., T, E., & R, C. (2024). Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study.. Annals of the rheumatic diseases. https://doi.org/10.1136/ard-2024-226129
Source records
- pubmed · retrieved 2026-09-26T03:24:07.596Z